世界の皮膚疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Skin Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6008
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、皮膚疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬用クリーム・軟膏、抗生物質、ビタミン・ステロイド、抗ヒスタミン薬、レーザー治療、抗真菌薬、その他）、用途別市場規模（皮膚科クリニック、スキンケアクリニック、病院、エステティックセンター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・皮膚疾患治療の市場動向
・企業の競争状況、市場シェア
・皮膚疾患治療の種類別市場規模と予測2016-2027（薬用クリーム・軟膏、抗生物質、ビタミン・ステロイド、抗ヒスタミン薬、レーザー治療、抗真菌薬、その他）
・皮膚疾患治療の用途別市場規模と予測2016-2027（皮膚科クリニック、スキンケアクリニック、病院、エステティックセンター、その他）
・皮膚疾患治療の北米市場規模2016-2027（アメリカ、カナダ）
・皮膚疾患治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・皮膚疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・皮膚疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・皮膚疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（APEIRON Biologics AG、HanAll BioPharma、GlaxoSmithKline plc.、Allergen, Plc.、Anacor Pharmaceuticals、Celgene、Basilea Pharmaceutica、Cipher Pharmaceuticals、Agenus、Astion Pharma A/S、Bristol-Myers Squibb、Almirall S.A.、Galderma）
・結論

Skin Disease is a general term for diseases that occur in the skin and skin accessory organs. There are many types of it, and visceral diseases can also be manifested on the skin.
There are many causes of skin diseases. For example, skin diseases caused by infectious factors, such as leprosy, scabies, fungal diseases, and skin bacterial infections, are often infectious, which not only affects physical health but also causes panic and social discrimination. With the improvement of living standards and the advancement of science and technology, infectious diseases such as leprosy have been significantly controlled worldwide.

Market Analysis and Insights: Global Skin Disease Treatment Market
The global Skin Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Disease Treatment market.

Global Skin Disease Treatment Scope and Market Size
Skin Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medicated Creams and Ointments
Antibiotics
Vitamins and Steroids
Antihistamines
Laser Therapy
Antifungals
Others

Segment by Application
Dermatology Clinics
Skincare Clinics
Hospitals
Aesthetic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
APEIRON Biologics AG
HanAll BioPharma
GlaxoSmithKline plc.
Allergen, Plc.
Anacor Pharmaceuticals
Celgene
Basilea Pharmaceutica
Cipher Pharmaceuticals
Agenus
Astion Pharma A/S
Bristol-Myers Squibb
Almirall S.A.
Galderma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicated Creams and Ointments
1.2.3 Antibiotics
1.2.4 Vitamins and Steroids
1.2.5 Antihistamines
1.2.6 Laser Therapy
1.2.7 Antifungals
1.2.8 Others
1.3 Market by Application
1.3.1 Global Skin Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology Clinics
1.3.3 Skincare Clinics
1.3.4 Hospitals
1.3.5 Aesthetic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Skin Disease Treatment Market Perspective (2016-2027)
2.2 Skin Disease Treatment Growth Trends by Regions
2.2.1 Skin Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Skin Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Skin Disease Treatment Industry Dynamic
2.3.1 Skin Disease Treatment Market Trends
2.3.2 Skin Disease Treatment Market Drivers
2.3.3 Skin Disease Treatment Market Challenges
2.3.4 Skin Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Skin Disease Treatment Players by Revenue
3.1.1 Global Top Skin Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin Disease Treatment Revenue
3.4 Global Skin Disease Treatment Market Concentration Ratio
3.4.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2020
3.5 Skin Disease Treatment Key Players Head office and Area Served
3.6 Key Players Skin Disease Treatment Product Solution and Service
3.7 Date of Enter into Skin Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Skin Disease Treatment Breakdown Data by Type
4.1 Global Skin Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Skin Disease Treatment Breakdown Data by Application
5.1 Global Skin Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Skin Disease Treatment Market Size (2016-2027)
6.2 North America Skin Disease Treatment Market Size by Type
6.2.1 North America Skin Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Skin Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Skin Disease Treatment Market Size by Type (2016-2027)
6.3 North America Skin Disease Treatment Market Size by Application
6.3.1 North America Skin Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Skin Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Skin Disease Treatment Market Size by Application (2016-2027)
6.4 North America Skin Disease Treatment Market Size by Country
6.4.1 North America Skin Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Skin Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Skin Disease Treatment Market Size (2016-2027)
7.2 Europe Skin Disease Treatment Market Size by Type
7.2.1 Europe Skin Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Skin Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Skin Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Skin Disease Treatment Market Size by Application
7.3.1 Europe Skin Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Skin Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Skin Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Skin Disease Treatment Market Size by Country
7.4.1 Europe Skin Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Skin Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Skin Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Skin Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Skin Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Skin Disease Treatment Market Size (2016-2027)
9.2 Latin America Skin Disease Treatment Market Size by Type
9.2.1 Latin America Skin Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Skin Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Skin Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Skin Disease Treatment Market Size by Application
9.3.1 Latin America Skin Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Skin Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Skin Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Skin Disease Treatment Market Size by Country
9.4.1 Latin America Skin Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Skin Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Skin Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Skin Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Skin Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 APEIRON Biologics AG
11.1.1 APEIRON Biologics AG Company Details
11.1.2 APEIRON Biologics AG Business Overview
11.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction
11.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2016-2021)
11.1.5 APEIRON Biologics AG Recent Development
11.2 HanAll BioPharma
11.2.1 HanAll BioPharma Company Details
11.2.2 HanAll BioPharma Business Overview
11.2.3 HanAll BioPharma Skin Disease Treatment Introduction
11.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2016-2021)
11.2.5 HanAll BioPharma Recent Development
11.3 GlaxoSmithKline plc.
11.3.1 GlaxoSmithKline plc. Company Details
11.3.2 GlaxoSmithKline plc. Business Overview
11.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction
11.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline plc. Recent Development
11.4 Allergen, Plc.
11.4.1 Allergen, Plc. Company Details
11.4.2 Allergen, Plc. Business Overview
11.4.3 Allergen, Plc. Skin Disease Treatment Introduction
11.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2016-2021)
11.4.5 Allergen, Plc. Recent Development
11.5 Anacor Pharmaceuticals
11.5.1 Anacor Pharmaceuticals Company Details
11.5.2 Anacor Pharmaceuticals Business Overview
11.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction
11.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021)
11.5.5 Anacor Pharmaceuticals Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Skin Disease Treatment Introduction
11.6.4 Celgene Revenue in Skin Disease Treatment Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Basilea Pharmaceutica
11.7.1 Basilea Pharmaceutica Company Details
11.7.2 Basilea Pharmaceutica Business Overview
11.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction
11.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2016-2021)
11.7.5 Basilea Pharmaceutica Recent Development
11.8 Cipher Pharmaceuticals
11.8.1 Cipher Pharmaceuticals Company Details
11.8.2 Cipher Pharmaceuticals Business Overview
11.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction
11.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021)
11.8.5 Cipher Pharmaceuticals Recent Development
11.9 Agenus
11.9.1 Agenus Company Details
11.9.2 Agenus Business Overview
11.9.3 Agenus Skin Disease Treatment Introduction
11.9.4 Agenus Revenue in Skin Disease Treatment Business (2016-2021)
11.9.5 Agenus Recent Development
11.10 Astion Pharma A/S
11.10.1 Astion Pharma A/S Company Details
11.10.2 Astion Pharma A/S Business Overview
11.10.3 Astion Pharma A/S Skin Disease Treatment Introduction
11.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2016-2021)
11.10.5 Astion Pharma A/S Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Almirall S.A.
11.12.1 Almirall S.A. Company Details
11.12.2 Almirall S.A. Business Overview
11.12.3 Almirall S.A. Skin Disease Treatment Introduction
11.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2016-2021)
11.12.5 Almirall S.A. Recent Development
11.13 Galderma
11.13.1 Galderma Company Details
11.13.2 Galderma Business Overview
11.13.3 Galderma Skin Disease Treatment Introduction
11.13.4 Galderma Revenue in Skin Disease Treatment Business (2016-2021)
11.13.5 Galderma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Skin Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicated Creams and Ointments
Table 3. Key Players of Antibiotics
Table 4. Key Players of Vitamins and Steroids
Table 5. Key Players of Antihistamines
Table 6. Key Players of Laser Therapy
Table 7. Key Players of Antifungals
Table 8. Key Players of Others
Table 9. Global Skin Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Skin Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Skin Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Skin Disease Treatment Market Share by Regions (2016-2021)
Table 13. Global Skin Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Skin Disease Treatment Market Share by Regions (2022-2027)
Table 15. Skin Disease Treatment Market Trends
Table 16. Skin Disease Treatment Market Drivers
Table 17. Skin Disease Treatment Market Challenges
Table 18. Skin Disease Treatment Market Restraints
Table 19. Global Skin Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Skin Disease Treatment Market Share by Players (2016-2021)
Table 21. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2020)
Table 22. Ranking of Global Top Skin Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Skin Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Skin Disease Treatment Product Solution and Service
Table 26. Date of Enter into Skin Disease Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Skin Disease Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Skin Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Skin Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Skin Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Skin Disease Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Skin Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Skin Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Skin Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Skin Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. APEIRON Biologics AG Company Details
Table 67. APEIRON Biologics AG Business Overview
Table 68. APEIRON Biologics AG Skin Disease Treatment Product
Table 69. APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. APEIRON Biologics AG Recent Development
Table 71. HanAll BioPharma Company Details
Table 72. HanAll BioPharma Business Overview
Table 73. HanAll BioPharma Skin Disease Treatment Product
Table 74. HanAll BioPharma Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. HanAll BioPharma Recent Development
Table 76. GlaxoSmithKline plc. Company Details
Table 77. GlaxoSmithKline plc. Business Overview
Table 78. GlaxoSmithKline plc. Skin Disease Treatment Product
Table 79. GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. GlaxoSmithKline plc. Recent Development
Table 81. Allergen, Plc. Company Details
Table 82. Allergen, Plc. Business Overview
Table 83. Allergen, Plc. Skin Disease Treatment Product
Table 84. Allergen, Plc. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. Allergen, Plc. Recent Development
Table 86. Anacor Pharmaceuticals Company Details
Table 87. Anacor Pharmaceuticals Business Overview
Table 88. Anacor Pharmaceuticals Skin Disease Treatment Product
Table 89. Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. Anacor Pharmaceuticals Recent Development
Table 91. Celgene Company Details
Table 92. Celgene Business Overview
Table 93. Celgene Skin Disease Treatment Product
Table 94. Celgene Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Celgene Recent Development
Table 96. Basilea Pharmaceutica Company Details
Table 97. Basilea Pharmaceutica Business Overview
Table 98. Basilea Pharmaceutica Skin Disease Treatment Product
Table 99. Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 100. Basilea Pharmaceutica Recent Development
Table 101. Cipher Pharmaceuticals Company Details
Table 102. Cipher Pharmaceuticals Business Overview
Table 103. Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 104. Cipher Pharmaceuticals Recent Development
Table 105. Agenus Company Details
Table 106. Agenus Business Overview
Table 107. Agenus Skin Disease Treatment Product
Table 108. Agenus Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 109. Agenus Recent Development
Table 110. Astion Pharma A/S Company Details
Table 111. Astion Pharma A/S Business Overview
Table 112. Astion Pharma A/S Skin Disease Treatment Product
Table 113. Astion Pharma A/S Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 114. Astion Pharma A/S Recent Development
Table 115. Bristol-Myers Squibb Company Details
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Skin Disease Treatment Product
Table 118. Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Almirall S.A. Company Details
Table 121. Almirall S.A. Business Overview
Table 122. Almirall S.A. Skin Disease Treatment Product
Table 123. Almirall S.A. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 124. Almirall S.A. Recent Development
Table 125. Galderma Company Details
Table 126. Galderma Business Overview
Table 127. Galderma Skin Disease Treatment Product
Table 128. Galderma Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
Table 129. Galderma Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medicated Creams and Ointments Features
Figure 3. Antibiotics Features
Figure 4. Vitamins and Steroids Features
Figure 5. Antihistamines Features
Figure 6. Laser Therapy Features
Figure 7. Antifungals Features
Figure 8. Others Features
Figure 9. Global Skin Disease Treatment Market Share by Application: 2020 VS 2027
Figure 10. Dermatology Clinics Case Studies
Figure 11. Skincare Clinics Case Studies
Figure 12. Hospitals Case Studies
Figure 13. Aesthetic Centers Case Studies
Figure 14. Others Case Studies
Figure 15. Skin Disease Treatment Report Years Considered
Figure 16. Global Skin Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Skin Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Skin Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 19. Global Skin Disease Treatment Market Share by Regions (2022-2027)
Figure 20. Global Skin Disease Treatment Market Share by Players in 2020
Figure 21. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Skin Disease Treatment Revenue in 2020
Figure 23. Global Skin Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 24. Global Skin Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 25. North America Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Skin Disease Treatment Market Share by Type (2016-2027)
Figure 27. North America Skin Disease Treatment Market Share by Application (2016-2027)
Figure 28. North America Skin Disease Treatment Market Share by Country (2016-2027)
Figure 29. United States Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Skin Disease Treatment Market Share by Type (2016-2027)
Figure 33. Europe Skin Disease Treatment Market Share by Application (2016-2027)
Figure 34. Europe Skin Disease Treatment Market Share by Country (2016-2027)
Figure 35. Germany Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Skin Disease Treatment Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Skin Disease Treatment Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Skin Disease Treatment Market Share by Region (2016-2027)
Figure 45. China Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Skin Disease Treatment Market Share by Type (2016-2027)
Figure 53. Latin America Skin Disease Treatment Market Share by Application (2016-2027)
Figure 54. Latin America Skin Disease Treatment Market Share by Country (2016-2027)
Figure 55. Mexico Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Skin Disease Treatment Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Skin Disease Treatment Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Skin Disease Treatment Market Share by Country (2016-2027)
Figure 61. Turkey Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. APEIRON Biologics AG Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 65. HanAll BioPharma Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 66. GlaxoSmithKline plc. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 67. Allergen, Plc. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 68. Anacor Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 69. Celgene Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 70. Basilea Pharmaceutica Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 71. Cipher Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 72. Agenus Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 73. Astion Pharma A/S Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 75. Almirall S.A. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 76. Galderma Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

以下、関連資料のご紹介

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の肌引き締めトリートメント市場規模・現状・予測（2021年-2027年）

Global Skin Tightening Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4869 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、肌引き締めトリートメントの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（高周波皮膚引き締め、レーザー皮膚引き締め、超音波皮膚引き締め、その他）、用途別市場規模（病院、ビューティーセンター、その他）、主...

世界のアジソン病用治療市場規模・現状・予測（2021年-2027年）

Global Addison's Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3763 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アジソン病用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口コルチコステロイド、コルチコステロイド注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の皮膚線維症治療市場規模・現状・予測（2021年-2027年）

Global Treatment of Skin Fibrosis Market Size, Status and Forecast 2021-2027
QFJ1-6052 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化剤、免疫療法薬、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年）

Global Lysosomal Storage Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4451 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、リソソーム蓄積症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、幹細胞移植、基質減少療法、その他）、用途別市場規模（病院、クリニック、幹細胞移植センター、研究機関、その他）、主要地域...

世界のICAD (頭蓋内アテローム性動脈硬化症) 病理学治療市場規模・現状・予測（2021年-2027年）

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5203 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ICAD (頭蓋内アテローム性動脈硬化症) 病理学治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステント、PTAバルーン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメ...

世界の認知症＆アルツハイマー病治療市場規模・現状・予測（2021年-2027年）

Global Dementia and Alzheimer’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5693 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、認知症＆アルツハイマー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コリンエステラーゼ阻害剤、メマンチン、併用薬）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年） Lysosomal storage disease (LTD) is caused by defect in lysosomal functions and degradation pathway. It is caused by progressive accumulation of metabolites. LTD is a rare inherited metabolic disorder. Market Analysis and Insights: Global Lysosomal Storage Disease Treatment Market The global Lysosoma…
世界の注射式しわ治療市場規模・現状・予測（2021年-2027年） Injectable anti –wrinkle are the treatment that are injected into the treatment area to reduce the skin lines and wrinkles. It can also fill the sagging skin and tighten the skin, reduce the frown lines, and lines under the eyes etc. The injectable anti-wrinkle treatment can help in rejuvenation of …
世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Medication Treatment …
世界の皮膚・軟部組織感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Skin and Soft Tissue Infection Treatment Market The global Skin and Soft Tissue Infection Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…